Harpoon Therapeutics Inc. (HARP)
NASDAQ: HARP
· Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM
Harpoon Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 17.74M | 32.8M | 61.38M | 51.61M | 50.37M | 68.57M | 50.74M | 44.69M | 42.99M | 77.41M | 71.33M |
Short-Term Investments | 13.87M | 12.76M | n/a | 1.5M | 15.73M | 21.59M | 61.73M | 90.41M | 108.39M | 93.6M | 158.08M |
Long-Term Investments | 206K | 673K | 673K | 673K | 673K | n/a | n/a | 1.52M | 2.84M | 4.19M | 9.99M |
Other Long-Term Assets | 692K | 492K | 107K | 238K | 138K | 869K | 813K | 860K | 700K | 747K | 805K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.69M | 3.51M | 2.48M | 1.61M | 3.05M | 3.88M | 4.48M | 2.6M | 4.8M | 4.66M | 4.87M |
Total Current Assets | 34.3M | 49.07M | 63.86M | 54.73M | 69.15M | 94.04M | 116.94M | 137.69M | 156.19M | 175.68M | 234.28M |
Property-Plant & Equipment | 12.38M | 12.97M | 16.17M | 18.09M | 13.54M | 14.04M | 14.69M | 15.38M | 14.94M | 15.56M | 16.24M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.28M | 14.13M | 16.95M | 19M | 14.35M | 14.91M | 15.5M | 17.76M | 18.48M | 20.5M | 27.04M |
Total Assets | 47.58M | 63.2M | 80.81M | 73.73M | 83.5M | 108.95M | 132.45M | 155.45M | 174.67M | 196.18M | 261.32M |
Account Payables | 3.44M | 3.63M | 4M | 4.71M | 2.64M | 2.79M | 4.19M | 2.67M | 1.6M | 2M | 2.64M |
Deferred Revenue | n/a | 4.45M | 22.36M | 30.94M | 33.96M | 36.5M | 36.88M | 37.46M | 38.15M | 34.82M | 30.84M |
Short-Term Debt | 2.97M | 2.88M | 2.79M | 2.42M | 1.83M | 1.77M | 1.71M | 1.65M | 1.59M | 1.54M | 1.48M |
Other Current Liabilities | 11.7M | 14.38M | 15.03M | 14.36M | 15.63M | 17.16M | 15.81M | 17.36M | 14.04M | 16.34M | 63.2M |
Total Current Liabilities | 18.11M | 25.33M | 44.17M | 52.43M | 54.06M | 58.22M | 58.58M | 59.14M | 55.38M | 54.69M | 98.16M |
Long-Term Debt | 11.53M | 12.29M | 12.82M | 13.58M | 9.14M | 9.63M | 10.09M | 10.54M | 10.97M | 11.4M | 11.8M |
Other Long-Term Liabilities | 13.4M | 22.58M | 20.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 24.93M | 34.87M | 35.92M | 15.9M | 12.52M | 24.09M | 32.48M | 38.24M | 42.32M | 50.55M | 60.77M |
Total Liabilities | 43.04M | 60.2M | 80.09M | 68.33M | 66.58M | 82.31M | 91.06M | 97.38M | 97.7M | 105.25M | 158.94M |
Total Debt | 14.5M | 15.17M | 15.61M | 16.01M | 10.97M | 11.4M | 11.8M | 12.19M | 12.56M | 12.94M | 13.28M |
Common Stock | 1K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -364.6M | -362.8M | -363.86M | -352.52M | -334.1M | -322.46M | -305.11M | -284.79M | -263.24M | -246.56M | -229.79M |
Comprehensive Income | 1K | 5K | n/a | -3K | -28K | -56K | -88K | -47K | n/a | -2K | -17K |
Shareholders Equity | 4.54M | 3M | 715K | 5.4M | 16.91M | 26.64M | 41.38M | 58.07M | 76.97M | 90.93M | 102.38M |
Total Investments | 13.87M | 12.76M | 673K | 1.5M | 15.73M | 21.59M | 61.73M | 180.82M | 111.24M | 97.8M | 168.07M |